Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Barr: Emergency contraceptive Plan B second quarter sales increased $12 mil. over the year-ago quarter due to the OTC launch in November 2006, Barr reports in an Aug. 8 analysts call ("1The Tan Sheet" March 5, 2007, In Brief and 2"The Tan Sheet" Nov. 13 2006, p. 8). The firm's total revenues for the quarter were $637 mil., up 81% from the same period in the prior year. With Plan B boosting its proprietary division sales, generic oral contraception sales also drove overall revenue. Integration of Croatian firm PLIVA acquired in 2006 is on track, the firm reports...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS100806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel